Log In
Print
BCIQ
Print
Print this Print this
 

Lyxumia, lixisenatide (AVE0010, ZP10)

  Manage Alerts
Collapse Summary General Information
Company Zealand Pharma A/S
DescriptionGlucagon-like peptide-1 receptor (GLP-1R; GLP1R) agonist
Molecular Target Glucagon-like peptide-1 receptor (GLP-1R) (GLP1R)
Mechanism of ActionGlucagon-like peptide-1 (GLP-1) receptor agonist
Therapeutic ModalityPeptide
Latest Stage of DevelopmentMarketed
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation

U.S. - Undisclosed Review (Treat Type II diabetes)

Partner

Sanofi


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today